GGrantIndex
Sort

130,381 grants matching hiv

Pathogenesis and Treatment of HIV Infection

$2,719,569
Henry C Lane · Niaid Extramural Activities · Z01 · FY2007 · AI

ADMINISTRATIVE AND TECHNICAL SUPPORT FOR HIV LAB ACTIVITIES IN BRAZIL

$2,719,530
Dr. Orlando C. Ferreira Jr · Fundacao Universitaria Jose Bonifacio · U62 · FY2008 · PS

Development of a Vaccine for HIVAIDS: Humoral Immunity

$2,718,739
Marjorie Robert-Guroff · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Obesogenic origins of maternal and child metabolic health involving dolutegravir (ORCHID)

$2,717,846
Elaine Janine Abrams · Columbia University Health Sciences · R01 · FY2023 · HD

Center for the Analysis & Management of the Multicenter AIDS Cohort Study

$2,717,823
Lisa P Jacobson · Johns Hopkins University · UM1 · FY2013 · AI

A STUDY OF HIGH RISK DRUG USE SETTINGS FOR HIV PREVENTIO

$2,717,563
Yale University · P01 · FY2000 · MH

Vanderbilt HIV Clinical Trials Unit

$2,716,438
David W Haas · Vanderbilt University · UM1 · FY2014 · AI

Harnessing CD4+ T cell responses for long-term protective immunity against HIV

$2,714,796
Rafi Ahmed · Scripps Research Institute, The · UM1 · FY2018 · AI

Evaluation of anal self-sampling in HIV men-who-have-sex-with-men (HIV MSM) populations

$2,714,016
Megan Clarke · Division Of Cancer Epidemiology And Genetics · ZIA · FY2024 · CA

PS10-1001, HIV PREVENTION PROJECTS

$2,713,662
Lyell S Collins · Nevada State Dept Of Hlth/Human Svcs · U62 · FY2010 · PS

Structural Genomics of Persistence Targets from M. tuberculosis

$2,712,827
James C Sacchettini · Texas A&M Agrilife Research · P01 · FY2010 · AI

HIV/AIDS Clinical Trials Unit

$2,712,311
John A Bartlett · Duke University · U01 · FY2009 · AI

Center for Addiction and Disease Risk Exacerbation

$2,711,586
Peter M. Monti · Brown University · P20 · FY2019 · GM

Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies

$2,711,483
Pamela J Bjorkman · California Institute Of Technology · P01 · FY2020 · AI

Regulation of innate immunity by self-adjuvated MRNA vaccines

$2,710,680
Chinnaswamy Jagannath · Methodist Hospital Research Institute · R01 · FY2025 · AI

Award of Part B - In Vitro Testing Resources for AIDS Therapeutics Development

$2,710,652
Roger Ptak · Southern Research Institute · N01 · FY2009 · AI

HIV/AIDS Clinical Trials Units University of Cape Town CTU 2020 to 2027

$2,709,730
Linda-Gail Bekker · University Of Cape Town · UM1 · FY2024 · AI

National HIV Surveillance System

$2,709,464
Barbara Jean Bolden · New Jersey State Dept/Health/Senior Srvs · U62 · FY2015 · PS

National HIV Surveillance System

$2,709,464
Barbara Jean Bolden · New Jersey State Dept/Health/Senior Srvs · U62 · FY2014 · PS

Mucosal Discovery Team

$2,708,828
Thomas N Denny · Duke University · U19 · FY2009 · AI

HIV RESPONSE OF THE MINISTRY OF HEALTH, MALAWI

$2,704,088
Emma Mabvumbe · Ministry Of Health, Malawi · U2G · FY2015 · GH

China's Integrated Programs for Research on AIDS

$2,704,029
National Center/Aids/Std Control/Prevent · U19 · FY2005 · AI

UNC MACS/WIHS Combined Cohort Study Clinical Research Site

$2,702,913
Michelle Floris-Moore · Univ Of North Carolina Chapel Hill · U01 · FY2024 · HL

Botswana-Harvard School of Public Health AIDS Initiative Partnership CTU

$2,702,555
Shahin Lockman · Harvard School Of Public Health · UM1 · FY2019 · AI

Structure-function analysis of infection- and vaccine-induced B-cell repertoires

$2,701,758
Stephen C Harrison · Boston Children'S Hospital · P01 · FY2021 · AI